Advanced Clinical: Asset Delivery

Upon signing your discovery to Advanced Clinical, you will find there are a lot of assets with your decision. Advanced Clinical is home of the Industry Leading Trial Performance Method, a method which carefully combines strategy, management, structures and execution strategies to advance discoveries.

Parts of our ILTP method include risk management, team integration, continuous learning, ramping/onboarding, project management with supply and demand management, recruiting and sourcing, and marketing.

Advanced Clinical takes a three-part overall approach to trials:

• Collaborate: One team approach, we work together
• Innovate: Work together to find the best technology and team members to find new ways of testing and advancing your discovery, apply the Industry Leading Trial Performance Method
• Optimize: Enhance the trial after it has begun with continuous learning and training, make step-change improvements to better the trial

Does this sound like a great way to advance discoveries? We think it is. Enter our “how do you advance discoveries” contest and your company could win an iPad and get a mention in our press release.

See www.advancedclinical.com

Big Pharma aims for reinvention

With some of his most profitable medicines going off patent, and the uncertainty of replacement drugs continuing to rise, US healthcare reform has been the least of Andrew Witty’s recent worries.

When the chief executive of GlaxoSmith­Kline presented his company’s most recent financial results last month, he gave a sense of how the UK’s biggest drugmaker – and the industry more generally – is responding to structural pressures: diversify to survive.

For his company, he says, this means a shift away from “white pills in western markets”, with the proportion of traditionally core patent-protected, chemically based drugs, which are sold mainly in North America and western Europe, falling to just more than a quarter of total sales.

For many years, large companies such as GSK have relied on a handful of typically high-priced, mass-market “blockbusters” that generate billions of dollars a year in sales. But as patents expire on drugs such as Lipitor, Pfizer’s anti-cholesterol medicine that is the biggest selling medication in history, big pharma is having to rethink its business model.

Most large pharmaceutical companies have adopted four principal strategies to diversify. First, expand the range of products in the research and development pipeline and the use of external as well as in-house scientists to discover them. Second, expand geographically, especially into emerging markets. Third, increase sales of products other than patented prescription medicines. Fourth, experiment with greater flexibility in pricing in different countries and with ways to ensure drugs provide value for money.

Read the rest of the article -- FinancialTimes.com

Visit us at www.advancedclinical.com

Risk Management from Advanced Clinical

Risk is a huge problem in clinical trials, and Advanced Clinical is swift and professional about identifying, assessing, prioritizing, mitigating and tracking risks to proactively avoid those risks – before they become issues that cause the trial to delay the trial. Some risks, unmitigated, can cause 2 years of delay! At a direct and indirect slippage cost of $6MM - $15MM/day, that adds up!

Advanced Clinical:

o Assesses risks
o Prioritizes risks
o Reduces uncertainty
o Mitigates risks
o Manages/monitors risks
o Optimizes procedures to reverse risks

Advanced Clinical recognizes the four types of risk: operational, strategic, financial, and market, so no area is overlooked. Advanced Clinical also assesses the scale of the impact, and the likelihood of occurrence of the risk over the trial period.

We want success and advancement for your discovery's trial as much as you do, and managing and mitigating risks is one of our keys to success.

Does this sound like a great way to advance discoveries? We think it is. Enter our “how do you advance discoveries” contest and your company could win an iPad and get a mention in our press release.

See www.advancedclinical.com

Women’s Cancer Awareness Week

With Mother's Day around the corner on May 9, it also marks the week for women's health and cancer awareness.

In spite of social leaps and bounds women have made in recent decades, there are still distinct differences between the bodies of men and women. There are many cancers that affect only women, or mostly women: breast cancer, fallopian tube cancer, ovarian cancer, uterine cancer, vaginal cancer, and vulvar cancer. Birth control pills can put women at risk of breast tenderness, gall bladder disease, bloating, nausea, acne, and headaches. Women are more susceptible to mood disorders like depression and anxiety.

Women go through menopause. Here is a great article from Google about how to ease symptoms of menopause and what to expect.

It's not all that bad being a lady, though. Women typically have a larger deep limbic system than men, which allows them to be more in touch with feelings and better able to express those feelings, which promotes bonding and friendship with others. Women are also blessed with the gifts of childbirth and breastfeeding, which form immediate and permanent bonds with her child.

Medicine is making new strides everyday to advance discoveries to ease symptoms, cure disease, and better the human situation. Enter our “how do you advance discoveries” contest and your company could win an iPad and get a mention in our press release.

See www.advancedclinical.com

DIA-bound? Join us for networking and brainstorming at Oya

Pharmaceutical, biotechnology, and medical device executives: are you going to the Drug Information Association (DIA) meeting in Washington, DC, June 13-17?

How do you advance discoveries? Join Advanced Clinical for cocktails, networking happy hour, brainstorming and make clinical trials better. We are meeting at Oya on Monday, June 14 at 5 p.m.

Oya is a beautiful contemporary Asia-French fusion restaurant and lounge in Penn Quarter, blocks from the DIA conference headquarters.

We hope you can join us! Please email jheneghan@advancedclinical.com for more details and to RSVP.

Don't forget! Enter our “how do you advance discoveries” contest and your company could win an iPad and get a mention in our press release.

See www.advancedclinical.com

Propel clinical trials with Continuous Learning

Advanced Clinical, the trusted CRO among the world's top pharmaceutical, biotechnology, and medical device companies, is enhancing Continuous Learning as a part of their Industry Leading Trial Performance method.

Advanced Clinical is experienced enough with trials to know that trials sometimes deviate from the original plan to improve scheduling, avoid risk, and improve efficiency and optimize the entire project. Continuous learning keeps everyone working on a trial up-to-date with those improvements. Change is not always good for a trial, but continuous learning and improvements means the right changes are being made.*

Continuous learning leads to success,** which is what AC wants for its clients.

Does this sound like a good way to advance discoveries? We think it is. Enter our “how do you advance discoveries” contest and your company could win an iPad and get a mention in our press release.

See www.advancedclinical.com

Sources:

*Is Change Always Good In Business?, Brian Chernett, CEO of the Academy for Chief Executives .

**Success Made Simple, Erik Wesner.

How do you advance discoveries? NOW--Win an iPad!

Now, winners receive an iPad and mention in our winners press release!

Shorten clinical trials. Reduce risk. Reduce cost! We need YOUR ideas!

Eighty billion drugs are predicted to come off patent in the next three years. While some say this release of patents may save money for the healthcare system as a whole because generics will take the place of those coming off patent, there is no replacement for many drugs and there are patients that need these drugs. As a result, Pharmaceuticals and Biotech companies have two key imperatives:

• "Advance discoveries", aka, reduce clinical trial timelines


• Reduce the escalating costs and risks associated with drug development

A recent article in the Wall Street Journal "Clinical Trial Death Watch" (March 16th 2010) echoes these imperatives. The message from the Wall Street Journal article is: there is a resounding need for efficiency and effectiveness to accelerate clinical trials. Even the government is trying to help with the acceleration of clinical trials. One recent study focused on collaboration. There are, however, still many complex issues that create barriers to realizing these imperatives. See, Forbes (March 26th, 2010 "Research and Markets: Investigating Clinical Trial Costs").

Advanced Clinical wants to ask pharmaceutical, biotechnology, and medical device companies, “How do you advance discoveries?” What are the best practices you use to shorten clinical trials? How do you reduce risk and cost in drug development? Do you have a strong risk management approach, employee training, or metrics management? Advanced Clinical would like your ideas to create Industry Leading Trial Performance in clinical research.

Let us know how you advance discoveries here. If you win, your ideas will be part of our press release in June, and you will win an iPad! The winning list of ideas will be posted on June 20, 2010.



For winning list announcement, you can follow Advanced Clinical on facebook or on one of our social networks:

Advanced Clinical Facebook Page
http://twitter.com/AdvClinical
http://youtube.com/AdvancedClinical
http://AdvancedClinical.blogspot.com
http://AdvancedClinical.wordpress.com

See www.advancedclinical.com